Company: MLTX
Filing Date: 2025-05-12
Form Type: 8-K
Source: 0001821586-25-000009
Chunk: 0

Company: MoonLake Immunotherapeutics
Filing Date: 2025-05-12
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On May 12, 2025, MoonLake Immunotherapeutics (the “ Company”) issued a press release announcing its financial results for the quarter ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

This Item 2.02 and the Press Release attached hereto as Exhibit 99.1, insofar as they disclose information regarding the Company’s results of operation and financial condition for the quarter ended March 31, 2025, are being furnished to the U. S. Securities and Exchange Commission.